Ronald A. Martell Named Chief Executive Officer Michael S. Perry, DVM, Ph.D., Named President and Chief Clinical Officer SOUTH SAN FRANCISCO, Calif., Feb. THREE (HSMN NewsFeed) — Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company…
Biopharmaceuticals
Poniard Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Poniard Pharmaceuticals Announces Management Changes and Reduction in Force”
Leave a Comment